Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.

Unsafe injections are suspected to occur routinely in developing countries. We carried out a literature review to quantify the prevalence of unsafe injections and to assess the disease burden of bloodborne infections attributable to this practice. Quantitative information on injection use and unsafe injections (defined as the reuse of syringe or needle between patients without sterilization) was obtained by reviewing the published literature and unpublished WHO reports. The transmissibility of hepatitis B and C viruses and human immunodeficiency virus (HIV) was estimated using data from studies of needle-stick injuries. Finally, all epidemiological studies that linked unsafe injections and bloodborne infections were evaluated to assess the attributable burden of bloodborne infections. It was estimated that each person in the developing world receives 1.5 injections per year on average. However, institutionalized children, and children and adults who are ill or hospitalized, including those infected with HIV, are often exposed to 10-100 times as many injections. An average of 95% of all injections are therapeutic, the majority of which were judged to be unnecessary. At least 50% of injections were unsafe in 14 of 19 countries (representing five developing world regions) for which data were available. Eighteen studies reported a convincing link between unsafe injections and the transmission of hepatitis B and C, HIV, Ebola and Lassa virus infections and malaria. Five studies attributed 20-80% of all new hepatitis B infections to unsafe injections, while three implicated unsafe injections as a major mode of transmission of hepatitis C. In conclusion, unsafe injections occur routinely in most developing world regions, implying a significant potential for the transmission of any bloodborne pathogen. Unsafe injections currently account for a significant proportion of all new hepatitis B and C infections. This situation needs to be addressed immediately, as a political and policy issue, with responsibilities clearly defined at the global, country and community levels.

[1]  W. Szmuness,et al.  Incidence of hepatitis B virus infections in preschool children in Taiwan. , 1982, The Journal of infectious diseases.

[2]  T R Bender,et al.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.

[3]  M. Mizokami,et al.  Study of needlestick accidents and hepatitis C virus infection in healthcare workers by molecular evolutionary analysis. , 1997, The Journal of hospital infection.

[4]  P. Van de Perre,et al.  Nosocomial Transmission of HIV in Africa: What Tribute Is Paid to Contaminated Blood Transfusions and Medical Injections? , 1988, Infection Control & Hospital Epidemiology.

[5]  N. Homedes,et al.  Medicines and Rural Health Services: An Experiment in the Dominican Republic , 1988 .

[6]  C. Collins,et al.  Microbiological hazards of occupational needlestick and 'sharps' injuries. , 1987, The Journal of applied bacteriology.

[7]  J. Culver,et al.  Preventing transmission of blood-borne pathogens: a compelling argument for effective device-selection strategies. , 1997, American journal of infection control.

[8]  J. Gerberding Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. , 1994, The Journal of infectious diseases.

[9]  Hepatitis C: global prevalence. , 1997, Releve epidemiologique hebdomadaire.

[10]  M. Kane Unsafe injections. , 1998, Bulletin of the World Health Organization.

[11]  D. Heymann,et al.  Acquired immunodeficiency syndrome in Romania , 1991, The Lancet.

[12]  H. Wyatt,et al.  Unnecessary injections and paralytic poliomyelitis in India. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[13]  R. Soeters,et al.  Hazards of Injectable Therapy , 1989, Tropical doctor.

[14]  N. Enomoto,et al.  A prospective study of hepatitis C virus infection after needlestick accidents. , 2008, Liver.

[15]  G. Grady,et al.  Hepatitis B immune globulin--prevention of hepatitis from accidental exposure among medical personnel. , 1975, The New England journal of medicine.

[16]  L. Simonsen,et al.  Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. , 1999, Bulletin of the World Health Organization.

[17]  G. Grady,et al.  Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. , 1982, Annals of internal medicine.

[18]  Y. Ko,et al.  Horizontal transmission of hepatitis B virus from siblings and intramuscular injection among preschool children in a familial cohort. , 1991, American journal of epidemiology.

[19]  D. Owens,et al.  Occupational exposure to human immunodeficiency virus and hepatitis B virus: a comparative analysis of risk. , 1992, The American journal of medicine.

[20]  H. Gayle,et al.  Risk factors for HIV infection among abandoned Romanian children , 1993, AIDS.

[21]  H. Birungi Injections and self-help: risk and trust in Ugandan health care. , 1998, Social science & medicine.

[22]  J. McCormick,et al.  The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan , 1997, Epidemiology and Infection.

[23]  W. Dolmans,et al.  Injection practices in Mwanza Region, Tanzania: prescriptions, patient demand and sterility , 1996, Tropical medicine & international health : TM & IH.

[24]  H. Wyatt,et al.  Unnecessary injections and poliomyelitis , 1993, Indian journal of pediatrics.

[25]  R. Fontaine,et al.  Plasmodium falciparum malaria transmitted in hospital through heparin locks , 1997, The Lancet.

[26]  D J Hu,et al.  Model-based estimates of the risk of human immunodeficiency virus and hepatitis B virus transmission through unsafe injections. , 1995, International journal of epidemiology.

[27]  M. Philip,et al.  Reusable Needles — A Major Risk Factor for Acute Virus B Hepatitis , 1993, Tropical doctor.

[28]  R. Marcus Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. , 1988, The New England journal of medicine.

[29]  C. Lafaix,et al.  Incidence of intramuscular injections in rural dispensaries in developing countries. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  H. Wyatt The popularity of injections in the Third World: origins and consequences for poliomyelitis. , 1984, Social science & medicine.

[31]  M. Brigaud,et al.  Injections and paralytic poliomyelitis in tropical Africa. , 1980, Bulletin of the World Health Organization.

[32]  G. Serjeant Blood transfusion in sickle cell disease , 1985 .

[33]  T. Greenhalgh Drug prescription and self-medication in India: an exploratory survey. , 1987, Social science & medicine.

[34]  W. Dolmans,et al.  Improved injection practices after the introduction of treatment and sterility guidelines in Tanzania , 1998, Tropical medicine & international health : TM & IH.

[35]  J. Brady,et al.  HIV infection in malnourished children in Harare, Zimbabwe. , 1997, East African medical journal.

[36]  A. Ferguson Commercial pharmaceutical medicine and medicalization: a case study from El Salvador. , 1981, Culture, Medicine and Psychiatry.

[37]  D. Krogstad,et al.  Allergy testing of multiple patients should no longer be performed with a common syringe. , 1984, The New England journal of medicine.

[38]  B. Lanphear,et al.  Hepatitis C Virus Infection in Healthcare Workers: Risk of Exposure and Infection , 1994, Infection Control & Hospital Epidemiology.

[39]  T. Quinn,et al.  RISK FACTORS FOR HUMAN IMMUNODEFICIENCY VIRUS SEROPOSITIVITY AMONG CHILDREN 1-24 MONTHS OLD IN KINSHASA, ZAIRE , 1986, The Lancet.

[40]  S. Whyte Pharmaceuticals as folk medicine: transformations in the social relations of health care in Uganda , 1992, Culture, medicine and psychiatry.

[41]  L. Hutwagner,et al.  Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice , 1995, BMJ.

[42]  C. King,et al.  High rate of hepatitis C virus infection in an isolated community: Persistent hyperendemicity or period‐related phenomena? , 1997, Journal of medical virology.

[43]  R. Bhatia,et al.  Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes. , 1998, Bulletin of the World Health Organization.

[44]  E. Tanaka,et al.  Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. , 1993, Archives of internal medicine.

[45]  H. Lane,et al.  Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. , 1990, Annals of internal medicine.

[46]  A. Fleming,et al.  Syringe Needles and Mass Inoculation Technique , 1951, British medical journal.